Amyotrophic Lateral Sclerosis (ALS) is a neurological disease that affects nerve cells in the brain and spinal cords which controls the activity of voluntary muscles. It is also termed as Lou Gehrig’s disease. There are several causes behind ALS which includes gene mutation, disorganized immune response, chemical imbalance etc. The symptoms for ALS mainly include fasciculation, respiratory problems, muscles weakness and cramps. The mortality rate in the ALS patients in high due to breathing problem.
Increasing in the number of patients affected with ALS is one of the major factor to drive the growth of ALS treatment market. Sporadic and familial are two types of ALS disease, in which sporadic disease is most common disease found with 90–95% of the overall cases in US and the government initiatives to examination the research for rare disease and FDA approvals creates an opportunity for various market players due to which the global market of amyotrophic lateral sclerosis treatment is expected to expand at healthy CAGR during the forecast period. Due to lower prevalence rate, awareness about the disease and low treatment availability hinder the growth of ALS treatment market.
Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
The global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Scope and Market Size
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
GNT Pharma
Amkor Pharma
Synthetic Biologics
Mitsubishi Tanabe Pharma
Avicena
Sanofi
...
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Type
Chemotherapy
Stem Cell Therapy
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Application
Hospitals
Diagnostic Centres
Clinics
Retail Pharmacies
Increasing in the number of patients affected with ALS is one of the major factor to drive the growth of ALS treatment market. Sporadic and familial are two types of ALS disease, in which sporadic disease is most common disease found with 90–95% of the overall cases in US and the government initiatives to examination the research for rare disease and FDA approvals creates an opportunity for various market players due to which the global market of amyotrophic lateral sclerosis treatment is expected to expand at healthy CAGR during the forecast period. Due to lower prevalence rate, awareness about the disease and low treatment availability hinder the growth of ALS treatment market.
Market Analysis and Insights: Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
The global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Scope and Market Size
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
GNT Pharma
Amkor Pharma
Synthetic Biologics
Mitsubishi Tanabe Pharma
Avicena
Sanofi
...
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Type
Chemotherapy
Stem Cell Therapy
Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Breakdown Data by Application
Hospitals
Diagnostic Centres
Clinics
Retail Pharmacies
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue
1.4 Market by Type
1.4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Stem Cell Therapy
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Centres
1.5.4 Clinics
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Perspective (2015-2026)
2.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Market Size
3.1.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue (2015-2020)
3.1.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio
3.2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2019
3.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players Head office and Area Served
3.4 Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Solution and Service
3.5 Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
5.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
6.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in North America (2019-2020)
6.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
6.4 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
7.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Europe (2019-2020)
7.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
7.4 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
8 China
8.1 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
8.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in China (2019-2020)
8.3 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
8.4 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
9.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Japan (2019-2020)
9.3 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
9.4 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
10.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
11 India
11.1 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
11.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in India (2019-2020)
11.3 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
11.4 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
12.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GNT Pharma
13.1.1 GNT Pharma Company Details
13.1.2 GNT Pharma Business Overview
13.1.3 GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020))
13.1.5 GNT Pharma Recent Development
13.2 Amkor Pharma
13.2.1 Amkor Pharma Company Details
13.2.2 Amkor Pharma Business Overview
13.2.3 Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.2.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.2.5 Amkor Pharma Recent Development
13.3 Synthetic Biologics
13.3.1 Synthetic Biologics Company Details
13.3.2 Synthetic Biologics Business Overview
13.3.3 Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.3.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.3.5 Synthetic Biologics Recent Development
13.4 Mitsubishi Tanabe Pharma
13.4.1 Mitsubishi Tanabe Pharma Company Details
13.4.2 Mitsubishi Tanabe Pharma Business Overview
13.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.4.5 Mitsubishi Tanabe Pharma Recent Development
13.5 Avicena
13.5.1 Avicena Company Details
13.5.2 Avicena Business Overview
13.5.3 Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.5.4 Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.5.5 Avicena Recent Development
13.6 Sanofi
13.6.1 Sanofi Company Details
13.6.2 Sanofi Business Overview
13.6.3 Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.6.5 Sanofi Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue
1.4 Market by Type
1.4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Stem Cell Therapy
1.5 Market by Application
1.5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Diagnostic Centres
1.5.4 Clinics
1.5.5 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Perspective (2015-2026)
2.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Growth Trends by Regions
2.2.1 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Market Size
3.1.1 Global Top Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Players by Revenue (2015-2020)
3.1.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio
3.2.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Revenue in 2019
3.3 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players Head office and Area Served
3.4 Key Players Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Product Solution and Service
3.5 Date of Enter into Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
5.2 Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
6.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in North America (2019-2020)
6.3 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
6.4 North America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
7.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Europe (2019-2020)
7.3 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
7.4 Europe Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
8 China
8.1 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
8.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in China (2019-2020)
8.3 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
8.4 China Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
9.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Japan (2019-2020)
9.3 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
9.4 Japan Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
10.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
11 India
11.1 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
11.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in India (2019-2020)
11.3 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
11.4 India Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size (2015-2020)
12.2 Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 GNT Pharma
13.1.1 GNT Pharma Company Details
13.1.2 GNT Pharma Business Overview
13.1.3 GNT Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.1.4 GNT Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020))
13.1.5 GNT Pharma Recent Development
13.2 Amkor Pharma
13.2.1 Amkor Pharma Company Details
13.2.2 Amkor Pharma Business Overview
13.2.3 Amkor Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.2.4 Amkor Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.2.5 Amkor Pharma Recent Development
13.3 Synthetic Biologics
13.3.1 Synthetic Biologics Company Details
13.3.2 Synthetic Biologics Business Overview
13.3.3 Synthetic Biologics Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.3.4 Synthetic Biologics Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.3.5 Synthetic Biologics Recent Development
13.4 Mitsubishi Tanabe Pharma
13.4.1 Mitsubishi Tanabe Pharma Company Details
13.4.2 Mitsubishi Tanabe Pharma Business Overview
13.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.4.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.4.5 Mitsubishi Tanabe Pharma Recent Development
13.5 Avicena
13.5.1 Avicena Company Details
13.5.2 Avicena Business Overview
13.5.3 Avicena Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.5.4 Avicena Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.5.5 Avicena Recent Development
13.6 Sanofi
13.6.1 Sanofi Company Details
13.6.2 Sanofi Business Overview
13.6.3 Sanofi Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Introduction
13.6.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Business (2015-2020)
13.6.5 Sanofi Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
